Teuza
Teuza is a venture capital fund established in 1992 and based in Haifa, Israel. The fund focuses on investing in companies across a range of sectors, including health tech, medical devices, software, electronics, biotechnology, telecommunications, and semiconductors, at various stages of development. Teuza typically invests between $500,000 and $4 million, often participating in multiple funding rounds. The fund is particularly interested in companies that possess breakthrough technologies, which can provide them with a competitive edge and the potential to become leaders in their respective markets. Teuza employs a hands-on approach, actively engaging in the management of its portfolio companies by taking board positions, influencing strategic decisions, and assisting in recruitment and budgeting. The fund is led by its CEO, Avi Kerbs, and its Chairman, Prof. Moshe Arens, a former Israeli minister of defense and ambassador to the United States.
TytoCare Ltd. specializes in developing handheld devices and applications that facilitate on-demand medical examinations, enabling users to connect with healthcare professionals for diagnosis and prescriptions from any location. The company's innovative tools allow users to assess various health parameters, including heart rate, lung function, skin conditions, and body temperature, effectively diagnosing common ailments such as ear infections, colds, flu, and respiratory issues. TytoCare offers three primary telehealth products: TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care settings. Each product features a modular examination tool and a comprehensive telehealth platform that supports data sharing, live video consultations, and appointment scheduling. Founded in 2012 and headquartered in Netanya, Israel, with an additional office in New York, TytoCare aims to empower individuals with accessible healthcare solutions and has established a strategic partnership with Novant Health.
TytoCare Ltd. specializes in developing handheld devices and applications that facilitate on-demand medical examinations, enabling users to connect with healthcare professionals for diagnosis and prescriptions from any location. The company's innovative tools allow users to assess various health parameters, including heart rate, lung function, skin conditions, and body temperature, effectively diagnosing common ailments such as ear infections, colds, flu, and respiratory issues. TytoCare offers three primary telehealth products: TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care settings. Each product features a modular examination tool and a comprehensive telehealth platform that supports data sharing, live video consultations, and appointment scheduling. Founded in 2012 and headquartered in Netanya, Israel, with an additional office in New York, TytoCare aims to empower individuals with accessible healthcare solutions and has established a strategic partnership with Novant Health.
TytoCare Ltd. specializes in developing handheld devices and applications that facilitate on-demand medical examinations, enabling users to connect with healthcare professionals for diagnosis and prescriptions from any location. The company's innovative tools allow users to assess various health parameters, including heart rate, lung function, skin conditions, and body temperature, effectively diagnosing common ailments such as ear infections, colds, flu, and respiratory issues. TytoCare offers three primary telehealth products: TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care settings. Each product features a modular examination tool and a comprehensive telehealth platform that supports data sharing, live video consultations, and appointment scheduling. Founded in 2012 and headquartered in Netanya, Israel, with an additional office in New York, TytoCare aims to empower individuals with accessible healthcare solutions and has established a strategic partnership with Novant Health.
MediaBoost takes an algorithmic approach to ad spend optimization, making the process of keyword bidding automatic for the advertiser. Rather than using rules of thumb, or trying to put guesstimates on the bid price for a certain keyboard, MediaBoost's flagship product, AdBooster, will do it for you.
DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era.
-The first really affordable Computer-to-Plate solution for quality in-house plate making
-Ideal for narrow web applications printers
-A great motivation to replace the traditional low quality film solution
-The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track
DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era.
-The first really affordable Computer-to-Plate solution for quality in-house plate making
-Ideal for narrow web applications printers
-A great motivation to replace the traditional low quality film solution
-The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track
MediaBoost takes an algorithmic approach to ad spend optimization, making the process of keyword bidding automatic for the advertiser. Rather than using rules of thumb, or trying to put guesstimates on the bid price for a certain keyboard, MediaBoost's flagship product, AdBooster, will do it for you.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.